← Back to Patent Explorer
US4657901A Expired / Lapsed US ⏱️ 0.0 years remaining

Pharmaceutical composition

Assignee: Sheiseido Co Ltd
•
Filing: 1984-09-07
•
Granted: 1987-04-14
•
Expires: 2004-09-07
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention concerns a composition for topical application which is greatly useful for the treatment of acne. The composition contains (1) a compound of the formula: ##STR1## or its ester or ether, (2) keratolytic agent and (3) pharmaceutically acceptable carrier.

Inventors

  • 👤 Haruhiko Ueda
  • 👤 Hidekazu Toyoda
  • 👤 Minoru Fukuda

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 10:38
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/56; A61K31/565

Claims Analysis

Total Claims: 20
Claim 1
Independent Claim 34 words
A composition for the topical treatment of acne, which comprises (1) an effective amount for treating acne of oxendolone or its ester or ether, (2) a keratolytic agent, and (3) a pharmaceutically acceptable carrier.
Claim 2
Dependent Claim 34 words
A composition for the topical treatment of acne, which comprises (1) an effective amount for treating acne of oxendolone or its ester or ether, (2) a keratolytic agent, and (3) a pharmaceutically acceptable carrier.
Claim 3
Dependent Claim 27 words
The composition according to claim 1, wherein the content of oxendolone is from about 0.001 W/V % to about 2 W/V % relative to the whole composition.
Claim 4
Dependent Claim 12 words
The composition according to claim 1, wherein the keratolytic agent is urea.
Claim 5
Dependent Claim 12 words
The composition according to claim 1, wherein the keratolytic agent is resorcinol.
Claim 6
Dependent Claim 41 words
The composition according to claim 1 wherein the oxendolone is from about 0.001 W/V % to about 2 W/V % relative to the whole composition and the keratolytic agent is present in an amount of 0.001 to about 15 W/V %.
Claim 7
Dependent Claim 33 words
The composition according to claim 1 which contains a gelling agent in an amount of 0.001 to about 20 W/V % and an alcohol in an amount of 5 to 70 W/V %.
Claim 8
Dependent Claim 16 words
The composition according to claim 1, wherein the composition comprises a gelling agent and/or an alcohol.
Claim 9
Dependent Claim 13 words
The composition according to claim 7, wherein the gelling agent is carboxyvinyl polymer.
Claim 10
Dependent Claim 12 words
The composition according to claim 7, wherein the alcohol is ethyl alcohol.
Claim 11
Dependent Claim 12 words
The composition according to claim 7, wherein the alcohol is benzyl alcohol.
Claim 12
Dependent Claim 17 words
The composition according to claim 7, which comprises oxendolone, urea, carboxyvinyl polymer, ethyl alcohol and benzyl alcohol.
Claim 13
Dependent Claim 17 words
The composition according to claim 7, which comprises oxendolone, resorcinol, carboxyvinyl polymer, ethyl alcohol and benzyl alcohol.
Claim 14
Dependent Claim 28 words
The composition according to claim 7, wherein the content of the oxendolone is from about 0.001 W/V % to about 2 W/V % relative to the whole composition.
Claim 15
Dependent Claim 12 words
The composition according to claim 7, wherein the keratolytic agent is urea.
Claim 16
Dependent Claim 12 words
The composition according to claim 7, wherein the heratolytic agent is resorcinol.
Claim 17
Independent Claim 37 words
A method of treatment of acne which comprises administering topically the composition containing (1) an effective amount for treating acne of oxendolone, or its ester or ether, (2) a keratolytic agent, and (3) a pharmaceutically acceptable carrier.
Claim 18
Independent Claim 37 words
A method of treatment of acne which comprises administering topically the composition containing (1) an effective amount for treating acne of oxendolone, or its ester or ether, (2) a keratolytic agent, and (3) a pharmaceutically acceptable carrier.
Claim 19
Dependent Claim 46 words
A method according to claim 16 wherein the oxendolone is present in an amount of from about 0.001 W/V % to about 2 W/V % relative to the whole composition and the keratolytic agent is present in an amount of 0.001 to about 15 W/V %.
Claim 20
Dependent Claim 33 words
A method according to claim 17 which contains a gelling agent in an amount of 0.001 to about 20 W/V % and an alcohol in an amount of 5 to 70 W/V %.

References Cited (Backward Citations)

US3856829A Cited
US4514385A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-04-13 1990-10-13 1991-04-14 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-04-13 1994-10-13 1995-04-14 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-04-13 1998-10-13 1999-04-14 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag